CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 



Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

Mateon Therapeutics Inc Growth Comparisons

Select each growth Category to receive further Information



OXGN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) - 3 % 9.71 % 8.63 %
Q / Q Revenue Growth (Q2 MRQ) - 8.67 % 5.78 % 2.88 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) - 3.5 % 4.3 % %
Seq. Revenue Growth (for 12 months ending Q2 TTM) - 0.77 % 1.41 % 2.29 %
Revenue 5 Year Average Growth - 12.13 % 11.74 % 14.44 %
Expected Revenue Growth (Y/Y) - - 1.89 % 3.04 %


OXGN's Growth Comparisons in II. Quarter 2018


You need to upgrade your Flash Player


Mateon Therapeutics Inc reported top-line of$ 0 millions in the second quarter 2018, compare to $ 0 millions in the same quarter a year ago. Biotechnology & Drugs industry grew by 3%, while Healthcare sector increased by 9.71%, and overall market improved by 8.63%.

Sequentially company's Revenue were unchanged from the first quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the second quarter 2018 earnings reports, average yearly sales growth is 14.44%.


Growth Rates of OXGN's Income in the second quarter 2018


OXGN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - -14.37 % -4.78 % 2.08 %
Seq. Operating Income Change (Q2 MRQ) - 3.91 % 8.94 % -4.26 %
Y / Y Operating Income Growth (Q2 TTM) - -15.78 % -19.71 % 10.04 %
Seq. Operating Income Growth (Q2 TTM) - -3.94 % -1.37 % 2.55 %
Operating Income 5 Year Avg. Change - 6.51 % -3.54 % 40.29 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -12.77 % 11.65 % 26.01 %
Seq. Income from Cont. Ops. Change (Q2 MRQ) - -11.03 % 23.78 % 6.61 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - -53.88 % -55.57 % 15.01 %
Seq. Income from Cont. Ops. Change (Q2 TTM) - -5.88 % 8.59 % 5.81 %
Income from Cont. Ops. 5 Year Avg. Change - -21.9 % -10.64 % 61.74 %

OXGN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -13.2 % 19.44 % 25.96 %
Q / Q Net Income Growth (Q2 MRQ) - -11.03 % 16.87 % 6.91 %
Y / Y Net Income Change (Q2 TTM) - -73.6 % -59.03 % 12.77 %
Seq. Net Income Change (Q2 TTM) - -5.97 % 11.42 % 5.93 %
Net Income 5 Year Avg. Growth - -22.72 % -14.01 % 62.09 %

OXGN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - 482.97 % 11.65 % 26.01 %
Seq. EPS from Cont. Ops. Change (Q2 MRQ) - -8.52 % 23.78 % 6.61 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q2 TTM) - - - 4.15 %
EPS from Cont. Ops. 5 Year Avg. Growth - -5.07 % -10.64 % 61.74 %


You need to upgrade your Flash Player

OXGN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - 480.08 % 19.44 % 61.74 %
Q / Q EPS Net Growth (Q2 MRQ) - -8.52 % 16.87 % 6.91 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 66.91 %
Seq. EPS Net Change (for 12 months ending Q2 TTM) - - - 4.14 %
EPS Net 5 Year Avg. Change - -22.72 % -14.01 % 62.09 %
Expected EPS Growth (Y/Y) - - 123.59 % 31.27 %



Mateon Therapeutics Inc reported bottom-line of $ -0.02 in the second quarter, compare to $ -0.15 in the same quarter a year ago. Biotechnology & Drugs industry grew by 480.08%, while Healthcare sector increased by 19.44%, and overall market improved by 25.96%.

Sequentially company's EPS were unchanged from the first quarter results. . Looking into annual growth, income per share grew by % on average in last five years, while S & P 500's including only Businesses with the second quarter 2018 financial results, average yearly income per share growth is 62.09%.

OXGN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - -17.54 % 1.21 % 72.59 %
Seq. Free Cash Flow Change (Q2 MRQ) - -14.62 % 29.24 % 59.78 %
Y / Y Free Cash Flow Change (Q2 TTM) - -2.41 % -0.72 % 10.34 %
Seq. Free Cash Flow Change (Q2 TTM) - -3.41 % -0.64 % 5.41 %
Free Cash Flow 5 Year Avg. Change - 11.8 % 7.65 % 168.67 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - -
Seq. Net Cash Flow Change (Q2 MRQ) - - - -
Y / Y Net Cash Flow Change (Q2 TTM) - 1804.14 % - -
Seq. Net Cash Flow Change (Q2 TTM) - -3.54 % - -
Net Cash Flow 5 Year Avg. Change - - - -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) - -16.95 % 14.67 % 19.88 %
Seq. Capital Expenditures Change (Q2 MRQ) - 192.1 % 22.01 % -2.8 %
Y / Y Capital Expenditures Change (Q2 TTM) - -26.82 % 0.54 % 1.29 %
Seq. Capital Expenditures Change (Q2 TTM) - -3.01 % 1.43 % -1.1 %
Capital Expenditures 5 Year Avg. Change - 13.14 % 17.38 % 8.22 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DY's Profile

Stock Price

DY's Financials

Business Description

Fundamentals

Charts & Quotes

DY's News

Suppliers

DY's Competitors

Customers & Markets

Economic Indicators

DY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071